Microorganisms were thought to cause serious disease. However, some types of the microorganisms can synthesize biologically active molecules and be used as therapeutics. More pharmaceutical companies have realized the values and directed their clinical development efforts towards microbial therapeutics. The potential of microbial therapeutics is evident in the probiotics and live bacterial prophylactic vaccines, as well as more the recent cases using fecal microbiota transplant to improve human health or cure certain diseases. Besides, microorganisms can be engineered as live therapeutics to perform specific functions in the human body. Benefits could include preventing infections, eliminating tumors, and treating metabolic disorders. Engineered living systems are considered the next generation of therapeutics. Producing therapeutics derived from the microbes has several advantages over traditional systems: decreased production costs, side effects, and dosage requirements.Request a Quote
The microbiome has progressively become an attractive target for potential therapeutics. However, one of the biggest difficulties is to determine cause-effect relationships and to design microbial therapeutics for these conditions. We are dedicated to offering a full list of microbial genomics services to accelerate the development of microbial therapeutics, including microbial whole genome sequencing, 16S/18S/ITS sequencing, metagenomics, metatranscriptomics, microbial epigenomics, prokaryotic RNA sequencing, as well as microbial ID and AMR profiling.
Note: Our service is for research use only, not for disease diagnosis or treatment.
Bacteria, archeae, fungi, protozoan, viruses.
Next-generation sequencing (NGS), long-read sequencing, quantitative PCR (qPCR), and other molecular biology techniques.
Illumina HiSeq/MiSeq, Nanopore systems, PacBio RSII, PacBio Sequel, Applied Biosystems real-time PCR platforms, et al.
Figure 1. The high-throughput sequencing analysis process.
Our bioinformatics analysis pipeline is flexible to your needs.
|Rank Abundance Curve
|Principal Components Analysis (PCA)
|BLASTX, KEGG, eggNOG, CAZy, CARD, ARDB etc.